Pharma feed

N
Eli Lilly and Co
Law 360· 02 Apr 2020

PTAB Upholds 3 Teva Migraine Patents Challenged By Eli Lilly

Law360 (April 1, 2020, 4:28 PM EDT) -- The Patent Trial and Appeal Board upheld all claims in three Teva Pharmaceutical patents covering its migraine biologic Ajovy that were challenged by Eli Lilly, giving a boost to Teva’s underlying infringement suit against its rival over a competing drug.

  • Eli Lilly and Co
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Bayer AG
Pharmaboardroom· 02 Apr 2020

Pharma Faces: Jorge Levinson, Bayer Romania

Appointed in August 2019 to head up Bayer Romania and Moldova’s Pharmaceuticals division, 15-year Bayer veteran Jorge Levinson may be new to the market but certainly not new to the general manager position.

  • Bayer AG
  • Management Changes
  • News Articles
  • News and Other Websites
N
Eli Lilly and Co
Law360· 02 Apr 2020

PTAB Upholds 3 Teva Migraine Patents Challenged By Eli Lilly

Law360 (April 1, 2020, 4:28 PM EDT) -- The Patent Trial and Appeal Board upheld all claims in three Teva Pharmaceutical patents covering its migraine biologic Ajovy that were challenged by Eli Lilly, giving a boost to Teva’s underlying infringement suit against its rival over a competing drug.

  • Eli Lilly and Co
  • Teva Pharmaceutical Industries Ltd
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Novo Nordisk AS
Bloomberg Law· 02 Apr 2020

Sanofi, Eli Lilly, Novo Nordisk Dodge Another Insulin RICO Suit

Sanofi-Aventis U.S. LLP , Eli Lilly & Co. , and Novo Nordisk Inc . beat more racketeering claims over their alleged scheme to overcharge for insulin while paying insurers kickbacks to cover their interchangeable drugs, when a New Jersey federal judge dismissed most of a lawsuit by Minnesota’s attorney general.

  • Novo Nordisk AS
  • Eli Lilly and Co
  • Sanofi
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Raytheon Company
GuruFocus· 02 Apr 2020

First Financial Bank, N.A. - Trust Division Buys iShares Core MSCI EAFE, Gilead Sciences Inc, Kellogg Co, Sells iShares MSCI EAFE, Vanguard Value, Raytheon Co

Hamilton, OH, based Investment company First Financial Bank, N.A. - Trust Division (Current Portfolio) buys iShares Core MSCI EAFE, Gilead Sciences Inc, Kellogg Co, iShares Core S&P Small-Cap, SPDR Select Sector Fund - Utilities, sells iShares MSCI EAFE, Vanguard Value, Raytheon Co, United Technologies Corp, Merck Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, First Financial Bank, N.A. - Trust Division.

  • Raytheon Company
  • First Financial Bank,
  • Kellogg Company
  • Gilead Sciences, Inc.
  • MSCI INC.
  • M&A Activities
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
FirstWord Pharma· 02 Apr 2020

GSK completes divestment of Horlicks and other Consumer Healthcare nutrition products in India and certain other markets

GSK today announced the completion of its divestment of Horlicks and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited ("GSK India"), and Hindustan Unilever Limited ("HUL").

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Celgene Corp
Obroncology· 02 Apr 2020

With Latest FDA Submission, Bristol Myers Keeps Pace With Celgene Milestones – OBR

Please wait while we retrieve your external webpage

  • Celgene Corp
  • US Food and Drug Administration
  • Pace Plc
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
The Financial Express· 02 Apr 2020

HUL completes merger with GSK Consumer Healthcare; buys Horlicks brand for Rs 3,045 crore

HUL had on December 3, 2018 announced its decision to merge GSK CH India in a deal that valued the latter at Rs 31,700 crore. Hindustan Unilever (HUL) said on Wednesday that it had acquired the Horlicks brand from GlaxoSmithKline Consumer Healthcare (GSK CH) for Rs 3,045 crore, exercising the option available in the original agreement made between its parent company Unilever and GSK.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
Devdiscourse· 02 Apr 2020

HUL acquires Horlicks for Rs 3,045 cr as company completes merger with GSK Consumer

Hindustan Unilever Ltd (HUL) on Wednesday announced the completion of merger of GlaxoSmithKline Consumer Healthcare Ltd (GSKCH) with itself, almost 15 months after the announcement of the mega deal. The board of HUL also gave its approval to the acquisition of the Horlicks brand from GSK for Rs 3,045 crore as part of an option available in the original agreement made between HUL and GSK.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
N
US Food and Drug Administration
Cardiac Interventions Today· 02 Apr 2020

FDA Approves AstraZeneca's Farxiga for Patients With Type 2 Diabetes

October 21, 2019—AstraZeneca announced that the FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.

  • US Food and Drug Administration
  • AstraZeneca PLC
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Daiichi Sankyo Co Ltd
Biospectrum Asia· 01 Apr 2020

Daiichi Sankyo, Ultragenyx partner for gene therapy manufacturing technology

Daiichi Sankyo will make an upfront payment of USD $125 million to Ultragenyx at the time of this agreement Japan based Daiichi Sankyo Company, Limited has announced that it has entered into a strategic partnership with US based Ultragenyx Pharmaceutical Inc. (hereafter Ultragenyx) for the non-exclusive use of Ultragenyx’s proprietary adeno associated virus (AAV) based gene therapy manufacturing technology.

  • Daiichi Sankyo Co Ltd
  • Partnerships and Alliances
  • News Articles
  • Licensed Content
N
Bayer AG
Cardiac Interventions Today· 01 Apr 2020

Bayer's Gadavist Injection Contrast Agent Approved for Use in Cardiac MR in CAD Patients

July 15, 2019—Bayer announced that the FDA has approved an expanded indication for the company’s Gadavist (gadobutrol) injection for use in cardiac MR to assess myocardial perfusion and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

  • Bayer AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
CNBC TV18· 01 Apr 2020

HUL completes merger of GSK Consumer with itself

Nearly 15 months after announcing the deal to merge GlaxoSmithKline Consumer Healthcare with itself, Hindustan Unilever Limited has successfully completed the merger. The last set of approvals came from the Mumbai and Chandigarh bench of the National Company Law Tribunal in February 2020.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
Yahoo· 01 Apr 2020

HUL acquires Horlicks for Rs 3,045 cr as company completes merger with GSK Consumer

New Delhi, Apr 1 (PTI) Hindustan Unilever Ltd (HUL) on Wednesday announced the completion of merger of GlaxoSmithKline Consumer Healthcare Ltd (GSKCH) with itself, almost 15 months after the announcement of the mega deal. The board of HUL also gave its approval to the acquisition of the Horlicks brand from GSK for Rs 3,045 crore as part of an option available in the original agreement made between HUL and GSK.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Daiichi Sankyo Co Ltd
Citybizlist· 01 Apr 2020

American Regent to Acquire a Daiichi Sankyo Affiliate API Manufacturing Facility in France

American Regent, Inc., a U.S. manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio, announced today that it will acquire Daiichi Sankyo Altkirch SARL, a Daiichi Sankyo company that has an Active Pharmaceutical Ingredient (API) pharmaceutical manufacturing plant in Altkirch, France.

  • Daiichi Sankyo Co Ltd
  • American Regent , Inc.
  • M&A Activities
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
Webwire· 01 Apr 2020

Unilever announces completion of Horlicks acquisition from GSK

HUL announced the merger of GlaxoSmithKline Consumer Healthcare Ltd with HUL on 3rd December 2018, in line with the company’s strategy to evolve the Foods and Refreshment portfolio into higher growth segments, subject to obtaining necessary approvals.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • Unilever PLC
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • Press Release Agencies
N
GlaxoSmithKline PLC
Deal Street Asia· 01 Apr 2020

India: HUL buys Horlicks as company completes merger with GSK Consumer

India’s largest packaged consumer goods company Hindustan Unilever Ltd (HUL) on Wednesday said it has completed its merger with GlaxoSmithKline Consumer Healthcare Ltd (GSKCH), over a year after the announcement of the mega-deal. The board of HUL also approved the acquisition of the Horlicks brand for India from GSK for ₹3,045 crore as part of an option available in the original agreement made between HUL and GSK.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
N
US Food and Drug Administration
Gmpnews· 01 Apr 2020

Lilly’s Taltz® (ixekizumab) Receives FDA Approval for the Treatment of Pediatric Patients

Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Taltz® (ixekizumab) injection, 80 mg/mL for the treatment of pediatric patients (ages 6 to under 18) with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

  • US Food and Drug Administration
  • Eli Lilly and Co
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Celgene Corp
Pharmaboardroom· 01 Apr 2020

Company Spotlight: BMS Romania

With the January 2019 acquisition of Celgene for an eye-watering USD 74 billion – the largest pharma acquisition in history – two of the sector’s most innovative oncology companies have joined forces to lead the charge against cancer.

  • Celgene Corp
  • M&A Activities
  • News Articles
  • News and Other Websites
N
Takeda Pharmaceutical Co Ltd
Gmpnews· 01 Apr 2020

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin)

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) granted a positive opinion for the extension of the marketing authorization of ADCETRIS® (brentuximab vedotin) and recommended its approval in combination with CHP (cyclophosphamide, doxorubicin, prednisone) as a treatment for adult patients with previously untreated systemic anaplastic large cell lymphoma (sALCL).

  • Takeda Pharmaceutical Co Ltd
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Translate Bio
Pharmaceutical Business Review· 01 Apr 2020

Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19

Sanofi’s vaccines global business unit Sanofi Pasteur has collaborated with Translate Bio for the development of a novel messenger RNA (mRNA) vaccine for COVID-19, the disease resulted due to the novel coronavirus SARS-CoV-2. The latest deal is said to leverage an existing agreement between the two companies established in 2018 for the development of mRNA vaccines for infectious diseases.

  • Translate Bio
  • Sanofi
  • Partnerships and Alliances
  • News Articles
  • News and Other Websites
N
Pfizer Inc.
Seeking Alpha· 01 Apr 2020

Pfizer prevails in patent dispute over emergency allergy med

A Delaware court has ruled that a patent held by privately held Belcher Pharmaceuticals for an epinephrine injection is invalid, agreeing with Pfizer's (PFE -1.4% ) view that the patent is an obvious variation of an old idea.

  • Pfizer Inc.
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
Regeneron Pharmaceuticals Inc
BioSpace· 01 Apr 2020

Sanofi and Regeneron Launch Second Kevzara Trial Against COVID-19

Regeneron and Sanofi dosed the first patient outside of the United States with the rheumatoid arthritis drug Kevzara as part of a second global clinical trial assessing the medication as a treatment for COVID-19, the disease caused by the novel coronavirus pandemic.

  • Regeneron Pharmaceuticals Inc
  • Sanofi
  • Clinical Trials
  • News Articles
  • News and Other Websites
N
US Food and Drug Administration
BioSpace· 01 Apr 2020

FDA Ends Zolgensma Data Manipulation Investigation, Places No Penalties on Novartis

photobyphm / Shutterstock After months of investigation, the U.S. Food and Drug Administration (FDA) will not bring any penalties against Novartis over the data manipulation of the gene therapy Zolgensma, a multi-million dollar treatment for spinal muscular atrophy.

  • US Food and Drug Administration
  • Novartis AG
  • Regulatory and Legal
  • News Articles
  • News and Other Websites
N
GlaxoSmithKline PLC
The Economic Times· 01 Apr 2020

HUL acquires Horlicks from GSK for Rs 3045 crore

Hindustan Unilever Limited (HUL), the country's biggest consumer goods firm, said it has acquired Horlicks brand from GSK Plc for Rs 3045 crore for the Indian market, exercising its option from the original agreement made between its parent Unilever and GSK.

  • GlaxoSmithKline PLC
  • Hindustan Unilever
  • GlaxoSmithKline Consumer Healthcare Ltd
  • M&A Activities
  • News Articles
  • News and Other Websites
1 2 3 4 5